Men’s Health: Enrollment Opening Soon

Fatigue, poor recovery, low libido, mood changes, and stubborn body composition shifts are not always aging. They can be signs of measurable hormonal dysfunction. The right treatment starts with the right labs.
Requires Crimson membership · $99/mo
Hypogonadism (clinically defined testosterone deficiency) affects an estimated up to 40% of men over 45. The condition is characterized not just by reduced libido, but by insulin resistance, reduced lean mass, increased adiposity, cardiovascular risk, bone density loss, and cognitive changes. These are biomarker-measurable outcomes, not subjective complaints.
The diagnostic challenge is that testosterone deficiency rarely presents as an obvious hormonal problem. It presents as fatigue that doesn’t resolve with sleep, as body composition that resists correction despite exercise, as mood disruption that appears to be psychological. Hormonal testing is the only way to distinguish hormonal dysfunction from its mimics.
A transport protein required to calculate free testosterone accurately. Without albumin, free testosterone calculations are unreliable — a step most standard panels skip.
Every Crimson men’s health protocol is built on a comprehensive hormonal workup, followed by physician-led treatment, objective monitoring, and ongoing refinement.
01
Total Testosterone, Free Testosterone, Albumin, SHBG, LH, FSH, Estradiol, Hemoglobin, Hematocrit, hsCRP, and Total PSA: 11 markers that together give a complete picture of the male hormonal system.
02
A licensed physician interprets your full panel, identifies contributing factors, and designs a protocol calibrated to your biology, not a standardized starting point.
03
Regular lab retesting produces specific, actionable data. Your physician reviews every result and adjusts your protocol (dose, formulation, or approach) based on what the numbers show, not how you feel.
04
Hormonal needs evolve with age, lifestyle, and treatment response. Crimson tracks your biomarker trends longitudinally, and your physician updates your protocol at every inflection point, not just on a fixed schedule.

Most TRT prescriptions are written without a complete hormonal picture. LH and FSH alone determine whether hypogonadism is primary or secondary — which changes everything about which therapy is appropriate.
LH and FSH determine the right therapy before anything is prescribed
Formulation and dose matched to your biology, not a standard starting point
Physician-only decisions: no algorithm prescribes for you
Your LH and FSH levels determine whether your hypogonadism is primary or secondary, and that distinction changes everything about which therapy is appropriate. Your lab results define the clinical indication. Your goals (including fertility preservation, delivery preference, and lifestyle) shape the protocol design. All of it is part of the decision.

Best for
Men who want reliable, consistent results. Weekly at-home injections are the gold-standard approach to TRT.
The most clinically established form of TRT. Subcutaneous or intramuscular administration provides elevated, steady testosterone with a well-characterized pharmacokinetic profile, dosed 1–2 times weekly for consistent serum levels.
Requires membership · $99/mo

Best for
Men who want a needle-free daily protocol for steadier testosterone levels without pills or injections.
A topical protocol for men seeking stable testosterone without injections or a pill schedule. Compounded for precise dose titration, with gradual transdermal absorption that supports consistent serum levels.
Requires membership · $99/mo

Best for
Men who want to naturally restore testosterone production while preserving fertility and avoiding exogenous hormones.
A selective estrogen receptor modulator that stimulates the body's own LH/FSH signaling, raising testosterone endogenously without testicular suppression or the dependency of traditional TRT.
Requires membership · $99/mo
Androgenetic alopecia is driven by DHT, a downstream metabolite of testosterone. Treatment is matched to severity, compliance profile, and whether oral or topical delivery is preferred.


Compounded topical delivering both DHT blockade (finasteride) and follicular vasodilation (minoxidil) in a single daily application. Localized delivery is designed to reduce systemic exposure compared with oral finasteride, preferred for patients where systemic exposure is a concern.
Requires membership · $99/mo

Compounded capsule combining systemic DHT reduction (finasteride), anagen phase extension (minoxidil), and keratin support (biotin). Suited for patients with advanced thinning, poor topical compliance, or those seeking comprehensive systemic coverage.
Requires membership · $99/mo

Advanced compounded topical with minoxidil, tretinoin, biotin, fluocinolone, and Vitamin E. Tretinoin enhances minoxidil absorption through the dermis; fluocinolone addresses scalp inflammation that can impair follicular environment. The broadest topical protocol, used where DHT-blocking agents are not indicated or are already addressed systemically.
Requires membership · $99/mo

Topical copper peptide serum targeting the follicular microenvironment. GHK-Cu supports collagen synthesis, scalp perfusion, and follicle regeneration signals. Used as a standalone treatment or in combination with other hair protocols.
Requires membership · $99/mo
Insulin resistance and excess adiposity suppress testosterone and accelerate cardiovascular risk. GLP-1 therapy addresses these root metabolic drivers and is frequently indicated alongside TRT for comprehensive outcomes.
When labs and goals indicate, targeted peptides may complement a hormonal protocol, addressing recovery, tissue repair, and GH signaling. Crimson evaluates candidacy based on your biomarker picture and clinical goals.
Start with labs. Build the right protocol from your biomarkers up.